{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T16:05:58Z","timestamp":1771603558375,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.diagmicrobio.2026.117287","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T23:27:44Z","timestamp":1769470064000},"page":"117287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of two bioinformatic algorithms for the interpretation of HIV-1 drug resistance and subtyping in Cameroon: Translational application for ART optimization in low-and middle-income countries"],"prefix":"10.1016","volume":"115","author":[{"given":"Joseph","family":"Fokam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4320-0982","authenticated-orcid":false,"given":"Naomi-Karell","family":"Etame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezechiel","family":"Ngoufack Jagni Semengue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Collins Ambe","family":"Chenwi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seth C.","family":"Inzaule","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e9sir\u00e9","family":"Takou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evariste","family":"Molimbou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex Durand","family":"Nka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derrick","family":"Tambe Ayuk Ngwese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davy-Hyacinthe","family":"Gouissi Anguechia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aude Christelle","family":"Ka\u2019e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gr\u00e2ce","family":"Beloumou Angong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandrine Claire","family":"Djupsa Ndjeyep","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurelie Minelle","family":"Kengni Ngueko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel Audrey","family":"Nayang Mundo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larissa Gaelle","family":"Moko Fotso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela Patricia","family":"Tueguem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent Kama\u00ebl","family":"Mekel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel Carlos","family":"Tommo Tchouaket","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel Martin","family":"Sosso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rogers","family":"Ajeh Awoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria-Mercedes","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Ceccherini-Silberstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Cecile","family":"Bissek Zoung-Kanyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Cappelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vittorio","family":"Colizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo-Federico","family":"Perno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicaise","family":"Ndembi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francois-Xavier","family":"Mbopi-Keou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Ndjolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2026.117287_bib0001","series-title":"World Health Organization, World Health Organization, Department of HIV\/AIDS, Centers for Disease Control and Prevention (U.S.)","author":"Haile-Selassie","year":"2017"},{"key":"10.1016\/j.diagmicrobio.2026.117287_bib0002","series-title":"Global action plan on HIV drug resistance 2017\u20132021 [Internet]","first-page":"40","year":"2017"},{"key":"10.1016\/j.diagmicrobio.2026.117287_bib0003","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.trsl.2016.12.007","article-title":"HIV and its relationship to insulin resistance and lipid abnormalities","volume":"183","author":"Non","year":"2017","journal-title":"Transl Res"},{"key":"10.1016\/j.diagmicrobio.2026.117287_bib0005","article-title":"Global, regional, and national prevalence of HIV-1 drug resistance in treatment-naive and treatment-experienced children and adolescents: a systematic review and meta-analysis","volume":"77","author":"Ge","year":"2024","journal-title":"eClinicalMed [Internet]"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2026.117287_bib0006","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3390\/pathogens11070724","article-title":"Point-of-Care Tests for HIV drug resistance monitoring: advances and potentials","volume":"11","author":"Chua","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.diagmicrobio.2026.117287_bib0007","series-title":"Antiretroviral Resistance in Clinical Practice [Internet]","article-title":"Benefits of resistance testing","author":"Descamps","year":"2006"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2026.117287_bib0008","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1186\/s12879-022-07453-9","article-title":"HIV-1 drug resistance genotyping success rates and correlates of Dried-blood spots and plasma specimen genotyping failure in a resource-limited setting","volume":"22","author":"Omooja","year":"2022","journal-title":"BMC Infect Dis"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2026.117287_bib0009","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1177\/135965350400900511","article-title":"HIV drug resistance testing: is the evidence really there?","volume":"9","author":"Dunn","year":"2004","journal-title":"Antivir Ther"},{"issue":"22","key":"10.1016\/j.diagmicrobio.2026.117287_bib0010","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000033897","article-title":"HIV-1 genotypic profiling ensures effective response to third-line antiretroviral therapy in Cameroon","volume":"102","author":"Mbouyap","year":"2023","journal-title":"Med (Baltim)"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2026.117287_bib0011","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1128\/JCM.06689-11","article-title":"Automating HIV drug resistance genotyping with RECall, a freely accessible sequence analysis tool","volume":"50","author":"Woods","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2026.117287_bib0012","article-title":"From sequence data to patient result: a solution for hiv drug resistance genotyping with exatype, end to end software for Pol-HIV-1 sanger based sequence analysis and patient HIV drug resistance result generation","volume":"19","author":"Kingwara","year":"2020","journal-title":"J Int Assoc Provid AIDS Care JIAPAC"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2026.117287_bib0013","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1128\/JCM.41.7.3265-3272.2003","article-title":"Evaluation of the editing process in human immunodeficiency virus type 1 genotyping","volume":"41","author":"Huang","year":"2003","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2026.117287_bib0014","first-page":"172","article-title":"Reasons for non-adherence to antiretroviral therapy among adult patients receiving free treatment at a tertiary care hospital in Delhi","volume":"35","author":"Lal","year":"2010","journal-title":"Indian J Community Med Publ Indian Assoc Prev Soc Med"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2026.117287_bib0016","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12981-023-00572-6","article-title":"Current ART, determinants for virologic failure and implications for HIV drug resistance: an umbrella review","volume":"20","author":"SeyedAlinaghi","year":"2023","journal-title":"AIDS Res Ther"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2026.117287_bib0017","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13756-020-00799-2","article-title":"First case of Dolutegravir and Darunavir\/r multi drug-resistant HIV-1 in Cameroon following exposure to Raltegravir: lessons and implications in the era of transition to Dolutegravir-based regimens","volume":"9","author":"Fokam","year":"2020","journal-title":"Antimicrob Resist Infect Control"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2026.117287_bib0018","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12879-019-3871-0","article-title":"HIV-1 drug resistance testing is essential for heavily-treated patients switching from first- to second-line regimens in resource-limited settings: evidence from routine clinical practice in Cameroon","volume":"19","author":"Takou","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2026.117287_bib0019","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12981-019-0252-0","article-title":"Viral suppression in adults, adolescents and children receiving antiretroviral therapy in Cameroon: adolescents at high risk of virological failure in the era of \u201ctest and treat","volume":"16","author":"Fokam","year":"2019","journal-title":"AIDS Res Ther"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2026.117287_bib0020","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1093\/jac\/dkw218","article-title":"Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa","volume":"71","author":"Boender","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2026.117287_bib0021","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1080\/21505594.2022.2106021","article-title":"Characterization of a novel HIV-1 circulating recombinant form, CRF91_cpx, comprising CRF02_AG, G, J, and U, mostly among men who have sex with men","volume":"13","author":"Topcu","year":"2022","journal-title":"Virulence"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2026.117287_bib0022","article-title":"HIV-1 subtype diversity and immuno-virological outcomes among adolescents failing antiretroviral therapy in Cameroon: A cohort study","volume":"18","author":"roi","year":"2023","journal-title":"PLOS ONE"},{"key":"10.1016\/j.diagmicrobio.2026.117287_bib0023","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1284815","article-title":"Characterization of HIV-1 CRF02_AG\/A3\/G unique recombinant forms identified among children in Larkana, Pakistan","volume":"13","author":"Rashid","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2026.117287_bib0024","doi-asserted-by":"crossref","first-page":"e03420","DOI":"10.1128\/spectrum.03420-22","article-title":"Evaluation of circulating and archived HIV-1 integrase drug-resistance variants among patients on third-line ART in Cameroon: implications for dolutegravir-containing regimens in resource-limited settings. Martinez MA, editor","volume":"10","author":"Fokam","year":"2022","journal-title":"Microbiol Spectr"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2026.117287_bib0025","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1093\/jac\/dkab004","article-title":"Baseline integrase drug resistance mutations and conserved regions across HIV-1 clades in Cameroon: implications for transition to dolutegravir in resource-limited settings","volume":"76","author":"Semengue","year":"2021","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2026.117287_bib0026","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/v15010018","article-title":"Dolutegravir-based regimen ensures high virological success despite prior exposure to efavirenz-based first-LINE ART in Cameroon: an evidence of a successful transition model","volume":"15","author":"Semengue","year":"2022","journal-title":"Viruses"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2026.117287_bib0031","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00705-011-0982-3","article-title":"Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in Cameroon","volume":"156","author":"Fokam","year":"2011","journal-title":"Arch Virol"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2026.117287_bib0032","article-title":"High performance of integrase genotyping on diverse HIV-1 clades circulating in Cameroon: toward a successful transition to dolutegravir-based regimens in low and middle-income countries","volume":"102","author":"Fokam","year":"2022","journal-title":"Diagn Microbiol Infect Dis [Internet]"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2026.117287_bib0033","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1128\/JCM.00656-17","article-title":"Comparative evaluation of subtyping tools for surveillance of newly emerging HIV-1 strains. Caliendo AM, editor","volume":"55","author":"Fabeni","year":"2017","journal-title":"J Clin Microbiol [Internet]"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889326000374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889326000374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T15:13:42Z","timestamp":1771600422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889326000374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0732889326000374"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2026.117287","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of two bioinformatic algorithms for the interpretation of HIV-1 drug resistance and subtyping in Cameroon: Translational application for ART optimization in low-and middle-income countries","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2026.117287","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117287"}}